Back

EventHorizon: A Foundation Model for Clinical Flow Cytometry

Medina Grespan, M.; Morrison, M.; O'Fallon, B.; Shean, R.; Spies, N. C.; Ng, D.

2026-06-22 bioinformatics
10.64898/2026.06.18.733197 bioRxiv
Show abstract

Flow cytometry is an essential tool for diagnosis of hematologic malignancies, but existing clinical workflows are highly dependent on expert manual interpretation. Existing machine learning approaches typically require extensive labeled data and are sensitive to variability in panel design, instrumentation, and laboratory workflows, limiting their generalizability. We present EventHorizon, a self-supervised foundation model for clinical flow cytometry that produces unified specimen-level representations from heterogeneous multi-panel data. EventHorizon employs a two-stage hierarchical transformer architecture with marker-aware tokenization, enabling seamless integration of cells measured across different antibody panels into a single shared latent space. We pre-train the model using a DINO-inspired self-distillation strategy with a variety of flow cytometry-specific augmentations on a dataset of more than 100,000 clinical specimens across 17 distinct panels. We evaluate the resulting embeddings on three clinically relevant classification tasks spanning common and rare panels, demonstrating that simple k-nearest neighbor probing of frozen EventHorizon embeddings achieves performance comparable to a fully supervised baseline model and a prior panel-specific self-supervised model. To ensure EventHorizon is not simply shortcut learning on features such as the markers/panels run for a given specimen, we perform a graph-theoretic analysis of EventHorizons latent space which argues that specimen embeddings are organized primarily by biological diagnosis. Taken together, these results demonstrate that EventHorizon produces biologically meaningful, panel-agnostic specimen representations from clinical flow cytometry data which, with further development and validation, could provide a potential basis for scalable, reproducible diagnostic support across diverse clinical laboratory settings.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Cytometry Part A
33 papers in training set
Top 0.1%
38.5%
2
Nature Communications
5641 papers in training set
Top 28%
5.3%
3
Patterns
78 papers in training set
Top 0.3%
4.7%
4
Briefings in Bioinformatics
354 papers in training set
Top 3%
3.4%
50% of probability mass above
5
Bioinformatics
1204 papers in training set
Top 5%
3.1%
6
Scientific Reports
3612 papers in training set
Top 37%
3.1%
7
Nature Machine Intelligence
70 papers in training set
Top 1.0%
3.0%
8
PLOS Computational Biology
1863 papers in training set
Top 12%
2.4%
9
PLOS ONE
5266 papers in training set
Top 44%
2.3%
10
BMC Bioinformatics
457 papers in training set
Top 4%
2.1%
11
Cell Reports Methods
165 papers in training set
Top 1%
2.1%
12
iScience
1154 papers in training set
Top 14%
2.1%
13
npj Precision Oncology
53 papers in training set
Top 0.8%
1.9%
14
Nature Methods
385 papers in training set
Top 4%
1.7%
15
BioData Mining
22 papers in training set
Top 0.5%
1.1%
16
Genome Biology
637 papers in training set
Top 7%
1.1%
17
npj Systems Biology and Applications
125 papers in training set
Top 2%
1.1%
18
Cancer Research Communications
51 papers in training set
Top 2%
0.9%
19
Cell Systems
201 papers in training set
Top 5%
0.8%
20
Clinical Chemistry
22 papers in training set
Top 0.4%
0.8%
21
BMC Methods
15 papers in training set
Top 0.2%
0.8%
22
PNAS Nexus
159 papers in training set
Top 4%
0.8%
23
Computational and Structural Biotechnology Journal
242 papers in training set
Top 7%
0.8%
24
Computers in Biology and Medicine
128 papers in training set
Top 5%
0.6%
25
Bioinformatics Advances
203 papers in training set
Top 5%
0.6%
26
Communications Biology
993 papers in training set
Top 37%
0.6%
27
GigaScience
212 papers in training set
Top 5%
0.6%
28
Cell
431 papers in training set
Top 12%
0.6%
29
eLife
5828 papers in training set
Top 70%
0.6%
30
Genome Medicine
183 papers in training set
Top 6%
0.6%